Treatment of antibody-mediated rejection after kidney transplantation

被引：4
|
作者：
Sureshkurnar, K. K. [1 ]
Oti, I. U. [1 ]
Baroody, S. C. [1 ]
Hussain, S. M. [1 ]
Carpenter, B. J. [1 ]
Nghiem, D. D. [2 ]
Marcus, R. J. [1 ]
机构：
[1] Allegheny Gen Hosp, Div Nephrol & Hypertens, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Div Transplantat, Pittsburgh, PA 15212 USA
来源：
TRANSPLANTATION PROCEEDINGS | 2008年 / 40卷 / 05期
关键词：
D O I：
10.1016/j.transproceed.2008.03.160
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：1373 / 1374
页数：2
相关论文
共 50 条
  • [1] Treatment of antibody-mediated rejection in kidney transplantation
    Venetz, Jean-Pierre
    Pascual, Manuel
    EJHP PRACTICE, 2008, 14 (05): : 21 - 24
  • [2] Subclinical Antibody-mediated Rejection After Kidney Transplantation: Treatment Outcomes
    Parajuli, Sandesh
    Joachim, Emily
    Alagusundaramoorthy, Sayee
    Blazel, Justin
    Aziz, Fahad
    Garg, Neetika
    Muth, Brenda
    Mohamed, Maha
    Mandelbrot, Didier
    Zhong, Weixong
    Djamali, Arjang
    TRANSPLANTATION, 2019, 103 (08) : 1722 - 1729
  • [3] KIDNEY ALLOGRAFT HISTOLOGIC EVOLUTION AFTER TREATMENT OF ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Joly, M.
    Olagne, J.
    Parissiadis, A.
    Vargas, G. Gautier
    Cognard, N.
    Muller, C.
    Perrin, P.
    Braun, L.
    Heibel, F.
    Essayidi, A.
    Moulin, B.
    Caillard, S.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 19 - 19
  • [4] Late Antibody-Mediated Rejection (AMR) after Kidney Transplantation
    Martina, M.
    Oppenheimer, F.
    Revuelta, I.
    Campistol Planas, J.
    Sole, M.
    Cid, J.
    Diekmann, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 325 - 325
  • [5] The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
    Lee, Juhan
    Kim, Beom Seok
    Park, Yongjung
    Lee, Jae Geun
    Lim, Beom Jin
    Jeong, Hyeon Joo
    Kim, Yu Seun
    Huh, Kyu Ha
    YONSEI MEDICAL JOURNAL, 2015, 56 (06) : 1638 - 1642
  • [6] Antibody-mediated rejection in kidney transplantation: an update
    Lucas, Jessica G.
    Co, Jeannie P.
    Nwaogwugwu, Uzoamaka T.
    Dosani, Imran
    Sureshkumar, Kalathil K.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (04) : 579 - 592
  • [7] Comparison of Clinical Characteristics and Outcomes of Early Antibody-Mediated Rejection and Late Antibody-Mediated Rejection after Kidney Transplantation
    Chen, G.
    Wu, Z.
    Wang, C.
    Liu, X.
    Li, Q.
    Chen, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 846 - 846
  • [8] Antibody-Mediated Rejection in Kidney Transplantation: A Review
    Puttarajappa, Chethan
    Shapiro, Ron
    Tan, Henkie P.
    JOURNAL OF TRANSPLANTATION, 2012, 2012
  • [9] Daratumumab for treatment of antibody-mediated rejection after ABO-incompatible kidney transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    SWISS MEDICAL WEEKLY, 2019, : 14S - 15S
  • [10] Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation
    Muller, Yannick D.
    Ghaleb, Nseir
    Rotman, Samuel
    Vionnet, Julien
    Halfon, Matthieu
    Catana, Emmanuelle
    Golshayan, Dela
    Venetz, Jean-Pierre
    Aubert, Vincent
    Pascual, Manuel
    TRANSPLANT INTERNATIONAL, 2018, 31 (04) : 451 - 455
12345